Moneycontrol PRO
HomeNewsBusinessMarketsHUL to underperform in short term given expensive valuations: Ashish Chaturmohta

HUL to underperform in short term given expensive valuations: Ashish Chaturmohta

In the medium term, HUL should farewell as it will be a key beneficiary of the rural demand recovery and one of the least impacted companies from COVID-19 led disruptions.

May 04, 2020 / 11:50 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    HUL is expected to underperform given the expensive valuations and poor quarterly performance, but, in the medium term, HUL could do well as it will be a key beneficiary of the rural demand recovery and one of the least impacted companies from COVID-19 led disruptions, Ashish Chaturmohta, Head of Technical and Derivatives, Sanctum Wealth Management., said in an interview with Moneycontrol’s Kshitij Anand.

    edited excerpts:

    Q) What is fuelling market rally on D-Street?

    A) As the coronavirus brought the global economy to a standstill, the market world over witnessed a rout. In April, bounce back was seen after a vertical fall.

    COVID-19 Vaccine

    Frequently Asked Questions

    View more
    How does a vaccine work?

    A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

    How many types of vaccines are there?

    There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

    What does it take to develop a vaccine of this kind?

    Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

    View more
    Show

    Initially, it was led by defensive sectors like FMCG and Pharma. Recently, it was fueled by Auto and Commodity relief rally along with Banks and IT sector.

    Q) As we close the month of April on a positive note after a massacre in March – how is May likely to pan out for investors. There is a very popular Wall Street adage ‘Sell in May and Go Away’? Do you think we could hold onto gains if not why?

    A) The Nifty50 has now retraced 50 percent of the whole decline, so the index is approaching a resistance zone in terms of retracement levels.

    It needs to be seen that the market can sustain at current levels and some profit booking may be expected.

    Q) What is your call on Banking and auto stocks which have run up quite sharply in the week gone by?

    A) Though banking stocks have rallied recently, they are not out of the woods yet and are still within a range of 6 weeks. So, banks need to show follow-through action from here on for a fresh rally to emerge.

    The auto sector was in pain long before the pandemic hit and was one the weakest sector. So, for now, it seems like a relief rally coming off a low base.

    Q) What are the important factors which investors could track in the coming week, and in the month of May which could dictate the trend for markets?

    A) Relaxation in lockdown, economic policy measures, and how the activity at the ground is picking level is likely to dictate the market direction, going forward.

    Results season has already started and it would provide a peek on how earnings will be impacted in next quarter.

    Q) What is your view on Tech Mahindra and HUL which came out with results on Thursday? What should investors do – buy, sell, or hold?

    A) The HUL result was disappointing with a volume de-growth of 7 percent, the number not seen even during the demonetisation period. Personal care and ice cream segments witnessed a soft demand leading to the weak performance of the company.

    In the short run, the stock is expected to underperform given the expensive valuations and poor quarterly performance. However, in the medium term, HUL should farewell as it will be a key beneficiary of the rural demand recovery and one of the least impacted companies from COVID-19 led disruptions.

    Tech Mahindra too disappointed the street with a 29 percent fall in earnings. COVID-19 led disruptions are bringing extraordinary changes in the business models of the IT industry. Hence, it will be important to see who all are able to adapt to the rapid changes.

    While the stock has corrected by about 35 percent over the last two months, it not expected to rally in the near term in absence of any strong trigger.

    Q) What are your view on RIL results and Rights issue and what should investors do? Do you see a positive/negative reaction on Monday?
    A) RIL reported a resilient performance in all the segments even in this challenging quarter. The company also announced a rights issue of Rs 53,125 crore. This is a step towards the company's target of becoming a zero-net debt company by end of current fiscal.

    Promoters are expected to fully subscribe to the rights issues which will instil confidence in investors' minds about promoters’ commitment to the business in addition to improving the balance sheet strength. We believe investors should take this positively.

    Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.

    Kshitij Anand
    Kshitij Anand is the Editor Markets at Moneycontrol.
    first published: May 4, 2020 11:50 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
    CloseOutskill Genai